Study: New vaccine “Sinopharma” protects against “Omicron”

Beijing (agencies)

The Chinese company “Sinopharma” announced that its new vaccine, based on proteins, offers better protection compared to its popular vaccine, because the new vaccine acts as an immune system booster against the mutated “Omicron”. A study by 1,800 researchers found that the Sinopharm vaccine, which contains parts of the vertebral protein of the virus, is seven times more effective in stimulating protective antibodies against Omicron, if taken six months after receiving both doses of the inactivated vaccine. , according to the Bloomberg news agency. The results of this study represent a lifeline for China, which has been able to protect the vast majority of its population against “Covid-19”, by closing borders and taking rapid containment measures.


Leave a Reply

Your email address will not be published. Required fields are marked *